Invention Application
US20050014783A1 Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
审中-公开
使用Rho激酶抑制剂治疗动脉瘤和心脏肥大
- Patent Title: Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
- Patent Title (中): 使用Rho激酶抑制剂治疗动脉瘤和心脏肥大
-
Application No.: US10857062Application Date: 2004-05-28
-
Publication No.: US20050014783A1Publication Date: 2005-01-20
- Inventor: William Dole , David Light , Baby Martin-McNulty , Sabine Schirm , Yi-Xin Wang
- Applicant: William Dole , David Light , Baby Martin-McNulty , Sabine Schirm , Yi-Xin Wang
- Applicant Address: DE Berlin
- Assignee: Schering Aktiengesellschaft
- Current Assignee: Schering Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Main IPC: A61K31/4409
- IPC: A61K31/4409 ; A61K31/47 ; A61K31/4725 ; A61K31/551 ; A61K31/5513 ; A61P9/00 ; A61P9/10 ; C07D401/12
Abstract:
The present invention is directed to a method for preventing or decreasing the incidence of or treating aneurysm or cardiac hypertrophy, comprising administering an effective amount of a rho-kinase inhibitor, such as fasudil, to a subject in need thereof.
Information query
IPC分类:
